Josh N. Vo - Concepedia

Author

Josh N. Vo

University of Michigan

Also Known As

J. Vo, J. Vo�, Jalyn Vo, Jean Vo, Jessie M. Vo, Josh N. Vo, Josh Vo

Publications

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Center for Translational Pathology Howard Hughes Medical Institute Michigan Medicine Washington University in St. Louis

About

Josh N. Vo is an author at University of Michigan specializing in medicine, cancer research, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	2.1K
2	Cell Biology	2	2	111
3	Immunology	2	2	111
4	Engineering	1	1	2K
5	Pathology	1	1	17

Josh N. Vo

Publications

Citations

H-Index

Page 1

	Year	Citations
The Landscape of Circular RNA in Cancer Josh N. Vo, Marcin Cieślik, Yajia Zhang, Cell EngineeringRna BiologyCircular RnaSystems BiologyMedicine	2019	2K
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer Lanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, Nature	2021	292
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran, Cancer Cell	2022	183
Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer Yuanyuan Qiao, Jae Eun Choi, Jean C. Tien, Nature Cancer Cell AutophagyMitophagyReceptor Tyrosine KinaseImmunologyAutophagy	2021	93
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers Kelly L. Harms, Lili Zhao, Bryan Johnson, Clinical Cancer Research	2021	85
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma Josh N. Vo, Yi‐Mi Wu, Jeanmarie Mishler, Nature Communications	2022	84
Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13 Jianzhang Yang, Yu Chang, Jean C. Tien, Journal of Medicinal Chemistry	2022	67
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer Lanbo Xiao, Jean C. Tien, Josh N. Vo, Cancer Research	2018	56
Comprehensive proteogenomic characterization of rare kidney tumors Ginny Xiaohe Li, Lijun Chen, Yi Hsiao, Cell Reports Medicine	2024	39
Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer Steven Kregel, Rohit Malik, Irfan A. Asangani, Clinical Cancer Research	2019	33

Page 1